Compare RYTM & PRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | PRM |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | N/A | 371 |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.9B |
| IPO Year | 2017 | N/A |
| Metric | RYTM | PRM |
|---|---|---|
| Price | $93.66 | $35.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $131.14 | $27.50 |
| AVG Volume (30 Days) | 555.5K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.34 | $30.45 |
| Revenue Next Year | $86.06 | $8.44 |
| P/E Ratio | ★ N/A | $51.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.99 | $13.16 |
| 52 Week High | $122.20 | $36.95 |
| Indicator | RYTM | PRM |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 64.69 |
| Support Level | $82.43 | $30.08 |
| Resistance Level | $100.69 | N/A |
| Average True Range (ATR) | 4.46 | 1.29 |
| MACD | 0.64 | 0.39 |
| Stochastic Oscillator | 81.49 | 81.01 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the company's retardant and foam products. The Specialty Products segment develops, produces, and markets phosphorus pentasulfide (P2S5)-based products used in lubricant additives, as well as in pesticide, mining chemical, and battery applications.